BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14725331)

  • 1. Use of Helicobacter pylori-specific antibodies in the evaluation of intestinal metaplasia and gastric dysplasia.
    Barbosa J; Dinis-Ribeiro M; Guilherme M; Filipe T; Lomba-Viana R; Guimarães MA; Lopes C
    Br J Biomed Sci; 2003; 60(4):175-9. PubMed ID: 14725331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Helicobacter pylori infection in patients with precancerous changes and gastric cancer.
    Farinati F; Valiante F; Germanà B; Della Libera G; Baffa R; Rugge M; Plebani M; Vianello F; Di Mario F; Naccarato R
    Eur J Cancer Prev; 1993 Jul; 2(4):321-6. PubMed ID: 8358284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-Helicobacter pylori immunoglobulin G (IgG) and IgA antibody responses and the value of clinical presentations in diagnosis of H. pylori infection in patients with precancerous lesions.
    Li S; Lu AP; Zhang L; Li YD
    World J Gastroenterol; 2003 Apr; 9(4):755-8. PubMed ID: 12679926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucosal IgA antibody against Helicobacter pylori in chronic gastritis and intestinal metaplasia detected by the Tes-Tape method in resection specimens after gastrectomy for gastric cancer.
    Matsukura N; Onda M; Tokunaga A; Matsuda N; Yamashita K
    Cancer; 1995 Mar; 75(6 Suppl):1472-7. PubMed ID: 7889477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Helicobacter pylori infection, glandular atrophy and intestinal metaplasia in superficial gastritis, gastric erosion, erosive gastritis, gastric ulcer and early gastric cancer.
    Zhang C; Yamada N; Wu YL; Wen M; Matsuhisa T; Matsukura N
    World J Gastroenterol; 2005 Feb; 11(6):791-6. PubMed ID: 15682469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Helicobacter pylori antibodies in relation to precancerous gastric lesions in a high-risk Chinese population.
    Zhang L; Blot WJ; You WC; Chang YS; Kneller RW; Jin ML; Li JY; Zhao L; Liu WD; Zhang JS; Ma JL; Samloff IM; Correa P; Blaser MJ; Xu GW; Fraumeni JF
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):627-30. PubMed ID: 8824365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection of Helicobacter pylori DNA in gastric juice by the polymerase chain reaction: comparison with findings in bacterial culture and the detection of tissue IgA and serum IgG antibodies against Helicobacter pylori.
    Matsukura N; Onda M; Tokunaga A; Kato S; Yamashita K; Ohbayashi M
    J Gastroenterol; 1995 Dec; 30(6):689-95. PubMed ID: 8963384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A negative Helicobacter pylori serology test is more reliable for exclusion of premalignant gastric conditions than a negative test for current H. pylori infection: a report on histology and H. pylori detection in the general adult population.
    Storskrubb T; Aro P; Ronkainen J; Vieth M; Stolte M; Wreiber K; Engstrand L; Nyhlin H; Bolling-Sternevald E; Talley NJ; Agréus L
    Scand J Gastroenterol; 2005 Mar; 40(3):302-11. PubMed ID: 15932171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlations among Helicobacter pylori infection and the expression of cyclooxygenase-2 and vascular endothelial growth factor in gastric mucosa with intestinal metaplasia or dysplasia.
    Liu D; He Q; Liu C
    J Gastroenterol Hepatol; 2010 Apr; 25(4):795-9. PubMed ID: 20492336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication.
    Leung WK; Lin SR; Ching JY; To KF; Ng EK; Chan FK; Lau JY; Sung JJ
    Gut; 2004 Sep; 53(9):1244-9. PubMed ID: 15306578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
    Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
    J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of serum markers for gastric cancer and its precursor diseases among high incidence and mortality rate of gastric cancer area.
    Gantuya B; Oyuntsetseg K; Bolor D; Erdene-Ochir Y; Sanduijav R; Davaadorj D; Tserentogtokh T; Uchida T; Yamaoka Y
    Gastric Cancer; 2019 Jan; 22(1):104-112. PubMed ID: 29934751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability to noninvasively diagnose gastric intestinal metaplasia in Hispanics or reverse the lesion with Helicobacter pylori eradication.
    Morales TG; Sampliner RE; Camargo E; Marquis S; Garewal HS; Fennerty MB
    J Clin Gastroenterol; 2001; 32(5):400-4. PubMed ID: 11319310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Helicobacter pylori and CagA status, serum gastrin, interleukin-8 and gastric acid secretion in gastric cancer.
    Konturek SJ; Starzynska T; Konturek PC; Karczewska E; Marlicz K; Lawniczak M; Jaroszewicz-Heigelman H; Bielanski W; Hartwich A; Ziemniak A; Hahn EG
    Scand J Gastroenterol; 2002 Aug; 37(8):891-8. PubMed ID: 12229962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori associated gastric intestinal metaplasia: Treatment and surveillance.
    Liu KS; Wong IO; Leung WK
    World J Gastroenterol; 2016 Jan; 22(3):1311-20. PubMed ID: 26811668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relation between IgG and IgA antibody titres against Helicobacter pylori in serum and severity of gastritis in asymptomatic subjects.
    Kreuning J; Lindeman J; Biemond I; Lamers CB
    J Clin Pathol; 1994 Mar; 47(3):227-31. PubMed ID: 8163693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of anti-Helicobacter pylori antibodies in serum and duodenal fluid in peptic gastroduodenal disease.
    Locatelli A; Catapani WR; Gomes CR; Silva CB; Waisberg J
    World J Gastroenterol; 2004 Oct; 10(20):2997-3000. PubMed ID: 15378781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum anti-Helicobacter pylori antibodies and gastritis.
    Yamamoto I; Fukuda Y; Mizuta T; Fukada M; Nishigami T; Shimoyama T
    J Clin Gastroenterol; 1995; 21 Suppl 1():S164-8. PubMed ID: 8775012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors for regression and progression of intestinal metaplasia (IM): A large population-based study from low prevalence area of gastric cancer (IM-predictor trial).
    Aumpan N; Vilaichone RK; Pornthisarn B; Chonprasertsuk S; Siramolpiwat S; Bhanthumkomol P; Nunanan P; Issariyakulkarn N; Ratana-Amornpin S; Miftahussurur M; Mahachai V; Yamaoka Y
    PLoS One; 2021; 16(8):e0255601. PubMed ID: 34379655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of
    Mera RM; Bravo LE; Camargo MC; Bravo JC; Delgado AG; Romero-Gallo J; Yepez MC; Realpe JL; Schneider BG; Morgan DR; Peek RM; Correa P; Wilson KT; Piazuelo MB
    Gut; 2018 Jul; 67(7):1239-1246. PubMed ID: 28647684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.